Mucosal Immune Defense Mechanisms of the Urinary Bladder

膀胱粘膜免疫防御机制

• 批准号: 8180007
• 负责人: MARCO COLONNA
• 金额: $ 36.1万
• 依托单位: WASHINGTON UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-07-01 至 2016-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8180007
• 关键词: Acute; Antibiotic Therapy; Antibodies; Arachidonic Acids; Bacteria; Bacterial Infections; Bacterial Model; Biological Markers; Bladder; Bladder Diseases; Bladder Tissue; Bladder mucosa; Bone Marrow; CSF3 gene; CXCL1 gene; Caspase Inhibitor; Cell Death; Cell Lineage; Cells; Chimera organism; Chronic; Chronic Cystitis; Coupled; Cytokine Signaling; Data; Defense Mechanisms; Development; Dexamethasone; Dichloromethylene Diphosphonate; Disease Outcome; Dose; Environment; Epithelium; Event; Exclusion; Excretory function; Experimental Models; Failure; Frequencies; Gene Expression; Hematopoietic; Host Defense; Hour; IL8 gene; Immune; Immunoglobulin A; Immunoglobulins; Immunology; Immunosuppressive Agents; Inbred C3H Mice; Inbred Strains Mice; Infection; Infective cystitis; Inflammation; Inflammatory; Inflammatory Response; Interleukin-5; Interleukin-6; Invaded; Investigation; Length; Life; Liposomes; Lower urinary tract; Maps; Mediating; Microbe; Mission; Modeling; Molecular; Molecular Genetics; Mucositis; Mucous Membrane; Mus; Nature; Outcome; Ovalbumin; Pathway interactions; Pattern; Pattern recognition receptor; Predisposition; Principal Investigator; Production; Proteomics; Recording of previous events; Recurrence; Regulation; Renal pelvis; Research; Research Personnel; Resistance; Resolution; Role; Serum; Signal Pathway; Signal Transduction; Sterility; Stimulus; Surface; TLR4 gene; Testing; Therapeutic Intervention; Time; Toxin; Urethra; Urinary tract; Urinary tract infection; Uropathogen; Uropathogenic E. coli; Urothelial Cell; Urothelium; Vaccine Design; Vaccines; adverse outcome; base; combat; cytokine; design; experience; insight; microbial; mutant; new therapeutic target; novel vaccines; pathogen; research study; response; wasting

DESCRIPTION (provided by applicant): Mucosal surfaces must allow the exchange of metabolites required for life into the host and excretion/exclusion of wastes and toxins out of the host, while also maintaining a first line of defense against invasive microbes. However, mucosal inflammation, elicited to combat microbial infection, can also damage the integrity of the mucosal barrier, if not controlled. Many mucosal surfaces are in constant or transient contact with microbes, yet the molecular mechanisms governing the extent of the inflammatory response at the mucosal surface and the molecular basis of a protective adaptive mucosal response are poorly understood. This proposal will investigate these mechanisms by assembling an experienced team of investigators with diverse and complimentary expertise to investigate the mucosal immune defense mechanisms of the urinary bladder against bacterial infection. We will test the hypothesis that the integration of immune signaling pathways within the first few hours of bacterial infection, including those from the bladder epithelium, constitute a mucosal immune checkpoint that has a profound impact upon the outcome of disease and bladder mucosal remodeling. The proposed research will utilize a simple and highly tractable murine model of lower urinary tract bacterial infection to probe these immune defense pathways of the bladder mucosa during acute, chronic and recurrent infection. The experimental approaches proposed will provide critical insights in the field of mucosal immunology. These studies will investigate the role of specific innate signaling pathways (Aim 1) and cellular responses (Aim 2) early in acute infection of naive mice, and the role of adaptive changes such as chronic inflammatory cell infiltrates and IgA production in establishing sensitivity to or protection from recurrent infection (Aim 3). These investigations will reveal new details of the mechanisms of mucosal defense against bacteria, broadening the understanding of the regulation of mucosal inflammation and the signaling between mucosal epithelia and immune cells, and thus advance our understanding of chronic and recurrent infection susceptibility and protection. These insights will contribute to the development of novel vaccines and therapeutics targeting the mucosa. PUBLIC HEALTH RELEVANCE: These experiments are designed to reveal new mechanisms of mucosal defense against bacteria. Such findings would advance our understanding of both protective and damaging inflammatory responses at the mucosa, potentially contributing to the design of vaccines and raising new avenues for therapeutic intervention in chronic inflammatory conditions of the mucosa.

描述（由申请人提供）：粘液表面必须允许将生命所需的代谢物交换到宿主中，并将废物和毒素排泄/排除出宿主，同时还保持对入侵微生物的第一道防线。然而，为对抗微生物感染而引起的粘膜炎症如果不加以控制，也会损害粘膜屏障的完整性。许多粘膜表面与微生物持续或短暂接触，但控制粘膜表面炎症反应程度的分子机制和保护性适应性粘膜反应的分子基础知之甚少。该提案将通过组建一个经验丰富的研究人员团队来研究这些机制，该团队具有多样化和互补的专业知识，以研究膀胱对细菌感染的粘膜免疫防御机制。我们将检验以下假设：在细菌感染的最初几个小时内，免疫信号通路（包括来自膀胱上皮的免疫信号通路）的整合构成了一个粘膜免疫检查点，对疾病和膀胱粘膜重塑的结果产生了深远的影响。拟议的研究将利用一个简单和高度听话的下尿路细菌感染的小鼠模型，以探测这些免疫防御途径的膀胱粘膜在急性，慢性和复发性感染。提出的实验方法将在粘膜免疫学领域提供重要的见解。这些研究将研究特异性先天信号通路（Aim 1）和细胞反应（Aim 2）在幼稚小鼠急性感染早期的作用，以及适应性变化（如慢性炎性细胞浸润和伊加产生）在建立对复发感染的敏感性或保护中的作用（Aim 3）。这些研究将揭示粘膜防御细菌机制的新细节，拓宽对粘膜炎症调节以及粘膜上皮和免疫细胞之间信号传导的理解，从而推进我们对慢性和复发性感染易感性和保护的理解。这些见解将有助于开发针对粘膜的新型疫苗和疗法。 公共卫生相关性：这些实验旨在揭示粘膜防御细菌的新机制。这些发现将促进我们对粘膜保护性和损伤性炎症反应的理解，可能有助于疫苗的设计，并为粘膜慢性炎症性疾病的治疗干预提供新的途径。